KBC Group NV Has $10.25 Million Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

KBC Group NV lessened its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 34.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 148,135 shares of the company’s stock after selling 77,236 shares during the quarter. KBC Group NV owned 0.12% of Henry Schein worth $10,251,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. ING Groep NV acquired a new stake in shares of Henry Schein in the 3rd quarter valued at $63,226,000. Holocene Advisors LP acquired a new position in Henry Schein in the third quarter valued at about $58,319,000. Southpoint Capital Advisors LP grew its stake in Henry Schein by 30.0% during the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock worth $189,540,000 after buying an additional 600,000 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of Henry Schein during the third quarter worth approximately $43,740,000. Finally, Bank of Montreal Can raised its stake in shares of Henry Schein by 365.6% in the third quarter. Bank of Montreal Can now owns 711,487 shares of the company’s stock valued at $52,095,000 after acquiring an additional 558,689 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. Jefferies Financial Group raised their price target on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Evercore ISI raised their target price on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and upped their price target for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Finally, Barrington Research reiterated an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a research report on Wednesday, November 6th. Seven research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Henry Schein has a consensus rating of “Moderate Buy” and a consensus target price of $79.30.

Henry Schein Stock Performance

HSIC stock opened at $79.87 on Thursday. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The company has a market cap of $9.96 billion, a P/E ratio of 32.87, a price-to-earnings-growth ratio of 2.04 and a beta of 0.89. The business’s fifty day moving average is $73.19 and its 200-day moving average is $71.27.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.32 earnings per share. Equities research analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current year.

Insider Activity

In related news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.14% of the stock is owned by company insiders.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.